Milgamma N

Thiamine Hydrochloride, Cyanocobalamin and Pyridoxine Hydrochloride, the active ingredients in Milgamma N, are a vitamin B complex presented as an intramuscular injection for intramuscular use. It addresses deficiencies of vitamins B1, B6 and B12 and related neuropathic conditions in patients requiring rapid repletion. GNH USA supplies Milgamma N as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milgamma N provides essential B‑vitamins for disorders of vitamin deficiency and associated neuropathy. - Vitamin B1 (thiamine) deficiency: restores thiamine levels and supports carbohydrate metabolism. - Vitamin B6 (pyridoxine) deficiency: normalizes amino‑acid metabolism and nerve function. - Vitamin B12 (cobalamin) deficiency: promotes red blood cell formation and myelin synthesis. - Peripheral neuropathy linked to B‑vitamin deficiency: alleviates sensory symptoms and improves nerve conduction.

Milgamma N is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Injection site pain or erythema - Mild headache - Transient nausea - Low‑grade fever - Dizziness - Mild pruritus at the site

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hypotension - Acute hemolysis in susceptible individuals - Stevens‑Johnson syndrome - Persistent neuropathic pain unrelated to deficiency - Serum electrolyte disturbances

Milgamma N should be used with attention to specific safety considerations. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: caution advised; monitor infant for signs of deficiency. - Renal impairment: adjust monitoring as reduced clearance may affect vitamin levels. - Known hypersensitivity to any B‑vitamin component: avoid administration. - Concomitant high‑dose oral B‑vitamin supplements: assess for potential excess. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Milgamma N may interact with other medicines that affect vitamin metabolism or immune response.

Major Interactions (Avoid): - Methotrexate: can increase risk of hematologic toxicity. - High‑dose anticonvulsants (e.g., phenytoin, phenobarbital): may accelerate B‑vitamin depletion.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may alter plasma vitamin B12 levels. - Metformin: can reduce B12 absorption, requiring monitoring. - Proton pump inhibitors: may impair B12 absorption from the gut.